(Q2)May 31, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q2)May 31, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q2)May 31, 2022 | (FY)Nov 30, 2021 | (Q4)Nov 30, 2021 | (Q2)May 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash, cash equivalents and federal funds sold | 17.08%109.53M | 224.36%195.88M | 224.36%195.88M | 220.10%93.55M | 1,045.39%60.39M | 1,045.39%60.39M | 752.97%29.22M | -8.70%5.27M | -8.70%5.27M | -72.49%3.43M |
-Cash and cash equivalents | 17.08%109.53M | 224.36%195.88M | 224.36%195.88M | 220.10%93.55M | 1,045.39%60.39M | 1,045.39%60.39M | 752.97%29.22M | -8.70%5.27M | -8.70%5.27M | -72.49%3.43M |
-Available for sale securities | 48.00%512.49M | 48.12%432.09M | 48.12%432.09M | 32.05%346.27M | 25.07%291.73M | 25.07%291.73M | 6.58%262.23M | 16.37%233.24M | 16.37%233.24M | 41.75%246.03M |
Receivables | 9,746.69%7.98M | 130.42%2.31M | 130.42%2.31M | 121.81%81.02K | 10,293.01%1M | 10,293.01%1M | 83.35%36.53K | 88.47%9.64K | 88.47%9.64K | 2.55%19.92K |
Total assets | 43.21%629.99M | 78.49%630.28M | 78.49%630.28M | 50.91%439.9M | 48.04%353.12M | 48.04%353.12M | 16.84%291.49M | 15.67%238.52M | 15.67%238.52M | 34.10%249.48M |
Liabilities | ||||||||||
Derivative product liabilities | 797.33%1.08M | -47.19%603.46K | -47.19%603.46K | -80.22%120.44K | 563.16%1.14M | 563.16%1.14M | -38.45%609.02K | -90.54%172.31K | -90.54%172.31K | -66.84%989.55K |
Payables | 106.17%11.82M | 328.95%28.02M | 328.95%28.02M | 85.22%5.73M | 166.25%6.53M | 166.25%6.53M | 70.45%3.09M | 84.23%2.45M | 84.23%2.45M | 43.78%1.82M |
-Accounts payable | 115.68%11.27M | 340.47%27.39M | 340.47%27.39M | 85.47%5.22M | 199.30%6.22M | 199.30%6.22M | 94.18%2.82M | 98.53%2.08M | 98.53%2.08M | 33.67%1.45M |
-Other payable | 8.15%547.91K | 100.14%626.94K | 100.14%626.94K | 82.63%506.61K | -16.59%313.25K | -16.59%313.25K | -23.93%277.4K | 31.75%375.55K | 31.75%375.55K | 105.61%364.65K |
Other liabilities | 35.51%305.91M | 126.30%364.56M | 126.30%364.56M | -17.94%225.75M | 57.82%161.09M | 57.82%161.09M | 16.57%275.1M | -4.42%102.08M | -4.42%102.08M | 112.75%235.99M |
Total liabilities | 37.65%318.81M | 132.97%393.18M | 132.97%393.18M | -16.93%231.61M | 61.19%168.77M | 61.19%168.77M | 16.75%278.8M | -4.77%104.7M | -4.77%104.7M | 107.34%238.8M |
Shareholders'equity | ||||||||||
Total stockholders'equity | 49.40%311.18M | 28.61%237.1M | 28.61%237.1M | 1,541.90%208.29M | 37.76%184.35M | 37.76%184.35M | 18.79%12.69M | 39.01%133.82M | 39.01%133.82M | -84.93%10.68M |
Total equity | 49.40%311.18M | 28.61%237.1M | 28.61%237.1M | 1,541.90%208.29M | 37.76%184.35M | 37.76%184.35M | 18.79%12.69M | 39.01%133.82M | 39.01%133.82M | -84.93%10.68M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.